| Q37073309 | Assessment of serum leptin, pregnancy-associated plasma protein A and CRP levels as indicators of plaque vulnerability in patients with acute coronary syndrome |
| Q36686141 | Examination of serum pregnancy-associated plasma protein A clinical value in acute coronary syndrome prediction and monitoring |
| Q36601679 | Identification of myocardial injury in the emergency setting |
| Q35947007 | Key questions and answers about pregnancy-associated plasma protein-A. |
| Q41216845 | Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach. |
| Q37696962 | PAPP-A as a marker of increased long-term risk in patients with chest pain |
| Q51315246 | Potentially pathogenic circulating autoantibodies to cardiac troponin are present in hemodialysis patients. |
| Q37386914 | Pregnancy associated plasma protein-A (PAPP-A) as an early marker for the diagnosis of acute coronary syndrome |
| Q37264355 | The value of biochemical markers for risk stratification prior to hospital admission in acute chest pain |
| Q36767359 | Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain |